Mission Statement

Afromics is on a mission to ensure African populations are equitably represented in genomics — driving inclusive healthcare innovation that benefits Africa and the world.

Headquartered in Cambridge, UK, Afromics is building a next-generation African biobank covering 5 million individuals over the next decade. This biobank will integrate genomic, MRI, clinical, phenotypic, and demographic data, offering an unprecedented resource for global research and discovery.

Harnessing the immense genetic diversity of African populations — the founding population of all humanity — Afromics aims to reshape the future of precision medicine, from more accurate disease diagnoses to the discovery of new drug targets. By placing African communities at the centre of genomic research, we’re fostering a future where medical advancements are representative, inclusive, and globally impactful.